Evidence map›Paper›PMID 19213840›Full record

ArticleEndocrinology2009

Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.

Jennifer L Fiori, Tie-Nian Zhu, Michael P O'Connell, Keith S Hoek, Fred E Indig, Brittany P Frank, Christa Morris, Sutapa Kole, Joanne Hasskamp, George Elias and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Jennifer L FioriLaboratories of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224-6825, USA.
Tie-Nian Zhu
Michael P O'Connell
Keith S Hoek
Fred E Indig
Brittany P Frank
Christa Morris
Sutapa Kole
Joanne Hasskamp
George Elias
Ashani T Weeraratna
Michel Bernier
National Institutes of Health · USHarry and Jeanette Weinberg Foundation · USMedStar Health · USNational Institute on Aging · USUniversity Hospital of Zurich · CH

Funding

NIA/RRB Confocal Imaging FacilityZICAG000615 · NIA · NATIONAL INSTITUTE ON AGING · PI INDIG, FRED · 2009 to 2025
$17.9M
Flow Cytometry Laboratory (Scientific Core)ZICAG000618 · NIA · NATIONAL INSTITUTE ON AGING · PI WENG, NAN-PING PETER · 2009 to 2025
$9.5M
Role of Protein Prenylation in NF-kappaB ActivationZ01AG000892 · NIA · NATIONAL INSTITUTE ON AGING · PI BERNIER, MICHEL · 2002 to 2008
$1.5M
Role of Filamin A in Inflammation and OncogenesisZIAAG000892 · NIA · NATIONAL INSTITUTE ON AGING · PI BERNIER, MICHEL · 2009 to 2011
$1.0M
Flow Cytometry Laboratory (Scientific Core)Z01AG000618 · NIA · NATIONAL INSTITUTE ON AGING · PI WERSTO, ROBERT · 2008 to 2008
$763k
Role of Wnt Signaling in melanoma metastasis and melanocyte differentiationZIAAG000450 · NIA · NATIONAL INSTITUTE ON AGING · PI WEERARATNA, ASHANI · 2009 to 2010
$462k
NIA/RRB Confocal Imaging FacilityZ01AG000615 · NIA · NATIONAL INSTITUTE ON AGING · PI BECKER, KEVIN · 2008 to 2008
$445k
Using gene expression profiles to elucidate mechanisms of melanoma progressionZIAAG000442 · NIA · NATIONAL INSTITUTE ON AGING · PI WEERARATNA, ASHANI · 2009 to 2010
$443k
Role of Wnt Signaling in melanoma differentiation and the "stemness" of melanomaZ01AG000450 · NIA · NATIONAL INSTITUTE ON AGING · PI WEERARATNA, ASHANI · 2008 to 2008
$265k
Intramural NIH HHS
6 · The paper itself

Abstract

The actin-binding protein filamin A (FLNa) affects the intracellular trafficking of various classes of receptors and has a potential role in oncogenesis. However, it is unclear whether FLNa regulates the signaling capacity and/or down-regulation of the activated epidermal growth factor receptor (EGFR). Here it is shown that partial knockdown of FLNa gene expression blocked ligand-induced EGFR responses in metastatic human melanomas. To gain greater insights into the role of FLNa in EGFR activation and intracellular sorting, we used M2 melanoma cells that lack endogenous FLNa and a subclone in which human FLNa cDNA has been stably reintroduced (M2A7 cells). Both tyrosine phosphorylation and ubiquitination of EGFR were significantly lower in epidermal growth factor (EGF)-stimulated M2 cells when compared with M2A7 cells. Moreover, the lack of FLNa interfered with EGFR interaction with the ubiquitin ligase c-Cbl. M2 cells exhibited marked resistance to EGF-induced receptor degradation, which was very active in M2A7 cells. Despite comparable rates of EGF-mediated receptor endocytosis, internalized EGFR colocalized with the lysosomal marker lysosome-associated membrane protein-1 in M2A7 cells but not M2 cells, in which EGFR was found to be sequestered in large vesicles and subsequently accumulated in punctated perinuclear structures after EGF stimulation. These results suggest the requirement of FLNa for efficient EGFR kinase activation and the sorting of endocytosed receptors into the degradation pathway.

Indexed as

BiopsyCell Line, TumorContractile ProteinsDNA, ComplementaryDown-RegulationEndocytosisErbB ReceptorsFilaminsHumansLysosomesMelanomaMicrofilament ProteinsPhosphotransferasesProto-Oncogene Proteins c-cblSignal TransductionTransfectionCBL protein, humanContractile ProteinsDNA, ComplementaryErbB ReceptorsFilaminsMicrofilament ProteinsPhosphotransferasesProto-Oncogene Proteins c-cbl

Identifiers

PMID19213840
PMCPMC2689793
OpenAlexW2100978222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.